Metabolomics Diagnostics Announces Partnership With Preeclampsia Foundation
Cork, Ireland, May 2022 – Irish diagnostics company Metabolomics Diagnostics announces its corporate partnership with the Preeclampsia Foundation. The Preeclampsia…
Read More
Metabolomics Diagnostics Announces Partnership with US company Renegade.bio to Launch Preeclampsia Test in USA Market
Metabolomics Diagnostics Announces Partnership with US company Renegade.bio to Launch Preeclampsia Test in USA Market Cork Ireland and San Francisco…
Read More
Metabolomic Diagnostics appoints Dr. Ana Panigassi as Head of Clinical Affairs
Metabolomic Diagnostics, the Ireland based, deep tech medical diagnostics company, today announced the appointment of Dr. Ana Panigassi to the…
Read More‘Plotting PPV and NPV Criterions in the ROC space – adding utility to biomarker analysis’ -MSACL
Metabolomic Diagnostics Robin Tuytten and Gregoire Thomas (SQU4RE- Metabolomic Diagnostics Partner) recently presented a webinar for the The Association for…
Read More
The Biomarker Multiplexing Capabilities Of LC-MS Technology
Metabolomic Diagnostics is delighted to announce that CEO Robin Tuytten will present “The Biomarker Multiplexing Capabilities Of LC-MS Technology: The…
Read More
Metabolomic Diagnostics appoints a new CEO and announces new funding
Metabolomic Diagnostics Little Island Cork, Ireland Metabolomic Diagnostics, the Ireland based deep tech medical diagnostics company, today announced the completion…
Read More